[Absorption characteristics of sulfamethoxazole combined with trimethoprim]. 1985

E Cid, and F Mella, and A Retamal

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000892 Anti-Infective Agents, Urinary Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. Antiseptics, Urinary,Antiinfective Agents, Urinary,Urinary Anti-Infective Agents,Urinary Antiinfective Agents,Agents, Urinary Anti-Infective,Agents, Urinary Antiinfective,Anti Infective Agents, Urinary,Urinary Anti Infective Agents,Urinary Antiseptics
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

E Cid, and F Mella, and A Retamal
January 1996, Pharmacotherapy,
E Cid, and F Mella, and A Retamal
January 1974, Maternidade e infancia; arquivos medicos-sociais,
E Cid, and F Mella, and A Retamal
October 1972, Chemical & pharmaceutical bulletin,
E Cid, and F Mella, and A Retamal
May 1972, Deutsche medizinische Wochenschrift (1946),
E Cid, and F Mella, and A Retamal
November 1973, The Journal of infectious diseases,
E Cid, and F Mella, and A Retamal
December 1980, The New England journal of medicine,
E Cid, and F Mella, and A Retamal
October 1987, Mayo Clinic proceedings,
E Cid, and F Mella, and A Retamal
July 1999, Mayo Clinic proceedings,
E Cid, and F Mella, and A Retamal
January 1977, Ugeskrift for laeger,
Copied contents to your clipboard!